Zinc caproate: Ecofriendly synthesis, structural characterization, and antibacterial action.

Antibacterial activity Medium-chain fatty acid zinc Medium-chain fatty acids Structural characterization Zinc caproate

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
21 Mar 2024
Historique:
received: 20 12 2023
revised: 19 02 2024
accepted: 20 03 2024
medline: 24 3 2024
pubmed: 24 3 2024
entrez: 23 3 2024
Statut: aheadofprint

Résumé

Disease-causing microorganisms such as Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) are among the primary contributors to morbidity and mortality of diarrhea in humans. Considering the challenges associated with antibiotic use, including antimicrobial resistance, this study aimed to develop a novel zinc-based agent for bacterial inactivation. To this end, zinc caproate (ZnCA) was synthesized using caproic acid (CA) and zinc oxide (ZnO) in anhydrous ethanol via the solvothermal method. Structural characterization techniques, including Fourier-transform infrared spectroscopy, single crystal X-ray diffraction analysis, and nuclear magnetic resonance spectroscopy, revealed the bidentate bridging coordination of zinc atoms with CA. The resulting two-dimensional ZnCA network was found to be composed of a distinct lamellar pattern, without any evident inter-layer interactions. Powder X-ray diffraction analysis, elemental analysis, and melting point analysis confirmed that ZnCA had an average particle size of 1.320 µm, a melting point of 147.2 °C, and a purity exceeding 98 %. Remarkably, ZnCA demonstrated potent antibacterial activity against E. coli and S. aureus, which exceeded the antibacterial efficacy of ZnO. ZnCA exerted its antibacterial effects by inhibiting biofilm formation, disrupting cell membrane integrity, increasing cell membrane permeability, and altering intracellular Ca

Identifiants

pubmed: 38521376
pii: S0378-5173(24)00264-3
doi: 10.1016/j.ijpharm.2024.124030
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124030

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jilong Xu (J)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China. Electronic address: 201712020212@stu.haut.edu.cn.

Hanzhen Qiao (H)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China. Electronic address: hzqiao@haut.edu.cn.

Liping Gan (L)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China.

Peng Wang (P)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China.

Jinrong Wang (J)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China. Electronic address: wangjr@haut.edu.cn.

Yaoming Cui (Y)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China.

Jiale Zhou (J)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China.

Qingyu Liu (Q)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China.

Yue Jiang (Y)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China.

Huadong Zhang (H)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China.

Kunfan Yang (K)

College of Bioengineering, Henan University of Technology, Lianhua Street 100, Zhengzhou 450001, China.

Classifications MeSH